Loading
Life sciences · Journal article
Techniques in Coloproctology · October 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Background Predicting clinical complete response (cCR) to total neoadjuvant therapy (TNT) helps optimize therapeutic strategies and identify the best candidates for a watch-and-wait strategy. This study aimed to develop a machine learning model to predict cCR to TNT in a mixed curative-intent cohort of patients with advanced rectal cancer, including selected oligometastatic cases treated with curative intent. Methods A retrospective analysis of a prospectively maintained database of consecutive rectal cancer patients treated with TNT with curative intent at three South Australian hospitals between 2019 and 2026 was performed. Least absolute shrinkage and selection operator (LASSO) analysis was used for variable selection, and ten machine learning algorithms were employed to develop prediction models for cCR. Model performance was evaluated using the area under the receiver-operating characteristic curve (AUROC). Results A total of 245 patients were identified, of whom 193 were assigned to the training set and 52 to the external validation set. LASSO identified albumin, clinical T stage, tumour length, systemic immune-inflammation index, extramural vascular invasion, platelet count, and body mass index as key predictors of cCR. Among the ten models, the logistic regression model performed best in the training set, achieving an AUROC of 0.817. In external validation, the multilayer perceptron (MLP) model achieved the highest predictive performance with an AUROC of 0.755. Conclusion Machine learning models based on seven pretreatment variables show promise in accurately predicting cCR following TNT in patients with advanced rectal cancer. On external validation, the MLP model demonstrated the strongest predictive performance with moderate discrimination. However, further validation in larger, non-metastatic/selected populations may be required before clinical implementation.